{"id":2394,"date":"2025-11-14T14:59:49","date_gmt":"2025-11-14T07:59:49","guid":{"rendered":"https:\/\/naviva.com.vn\/?p=2394"},"modified":"2026-10-05T13:27:43","modified_gmt":"2026-10-05T06:27:43","slug":"barycela-inj-varicella-vaccine-korea","status":"publish","type":"post","link":"https:\/\/naviva.com.vn\/en\/barycela-inj-varicella-vaccine-korea","title":{"rendered":"BARYCELA inj. Varicella Vaccine (Korea)"},"content":{"rendered":"

Barycela inj.<\/a> varicella vaccine.<\/strong><\/span><\/h2>\n

Barycela inj. is an effective varicella vaccine for children aged 12 months to 12 years. When administered, the vaccine stimulates the immune system to actively produce specific antibodies, helping protect children against the varicella-zoster virus, reduce the risk of infection, and prevent serious complications.<\/span><\/p>\n

The vaccine contains live attenuated varicella-zoster virus of the MAV\/06 strain. It is formulated as a lyophilized powder for injection and administered by the subcutaneous route. According to the product registration dossier approved by the Drug Administration of Vietnam, each 0.5 ml dose after reconstitution contains a minimum of 3,800 PFU, ensuring consistent protective efficacy and stability throughout its shelf life.<\/span><\/p>\n

This article provides information about Barycela inj., including its indications, eligible users, dosage, administration, contraindications, warnings, adverse reactions, and storage conditions. The content is compiled from product information and reliable medical references.<\/span><\/p>\n

Antibiotic-free Barycela inj. varicella vaccine.<\/strong><\/span><\/h2>\n

According to the manufacturer, Barycela inj. is produced using advanced manufacturing technology aimed at eliminating the use of antibiotics through process improvements. The final vaccine product does not contain antibiotics, helping reduce concerns about the risk of antibiotic-related allergic reactions in children. This may also support healthcare professionals in providing consultations and give parents greater peace of mind when choosing a disease prevention solution.<\/span><\/p>\n

The composition of 0.5 mL of reconstituted Barycela inj. contains:<\/span><\/p>\n\n\n\n\n
Active ingredient<\/span><\/td>\nLive attenuated varicella virus<\/span><\/p>\n

(Strain: MAV\/06; cell line: MRC-5 )…………………….. \u2265 3,800 PFU<\/span><\/td>\n<\/tr>\n

Excipients<\/span><\/td>\nPotassium dihydrogen phosphate \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u20260.06 mg<\/span><\/p>\n

Dibasic sodium phosphate hydrate \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.1.14 mg<\/span><\/p>\n

Sodium L-glutamate hydrate \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026…0.40 mg<\/span><\/p>\n

Sucrose \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026…18.21 mg<\/span><\/p>\n

L-cysteine \u2026\u2026\u2026\u2026\u2026\u2026…\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u20260.18 mg<\/span><\/p>\n

Glycine \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u20261.82 mg<\/span><\/p>\n

Disodium edetate hydrate \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u20260.18 mg<\/span><\/p>\n

Urea \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.0.87 mg<\/span><\/p>\n

Gelatin \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.8.74 mg<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

Before vaccination, individuals should undergo medical examination and screening in accordance with applicable regulations. This includes assessing factors such as allergy history, immune status, existing medical conditions, current medications, and the contraindications specified in the product information.<\/span><\/p>\n

Pre-vaccination assessment helps healthcare professionals evaluate the individual\u2019s health status and determine whether the vaccine is appropriate for each specific case.<\/span><\/p>\n

For more information about the composition of Barycela inj. and the relevant information regarding the varicella vaccine without antibiotics in the finished product, please refer to the detailed article below:<\/span><\/p>\n

Antibiotic-free Barycela varicella vaccine<\/a><\/span><\/p>\n

Indications and eligible users <\/strong><\/span><\/h2>\n

Barycela inj. is a live attenuated varicella vaccine indicated for active immunization against chickenpox caused by the varicella-zoster virus.<\/span><\/p>\n

Barycela inj. is indicated for children aged 12 months to 12 years.<\/span><\/p>\n

Recommended 2-dose schedule:<\/span><\/p>\n